Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Not Available].

Bulletin du cancer - 1 Jun 2016

Mosca Matthieu, Vertenoeil Gaëlle, Toppaldoddi Katte Rao, Plo Isabelle, Vainchenker William

Abstract excerpt

BIOLOGICAL ASPECTS OF JAK/STAT SIGNALING IN BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: Myeloproliferative disorders more recently named Myeloproliferative neoplasms (MPN) display several clinical entities: chronic myeloid leukemia (CML), the classical MPN including polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF) and atypical and unclassifiable NMP. The term MPN is mostly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to Fusion Proteins, bcr-abl
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Receptors, Thrombopoietin

Share to Signal Transduction

Share to STAT Transcription Factors

Source

Identifiers

PMID: 27494969
DOI: 10.1016/S0007-4551(16)30142-4

Genes

JAK2
BCR
CALR
MPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Not Available].PMID 27494969Read ↗

[Not Available].Semantic proximity Read ↗

Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapy.Semantic proximity Read ↗

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemiaSemantic proximity Read ↗

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overviewSemantic proximity Read ↗

Myeloproliferative Neoplasms.Semantic proximity Read ↗

BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

[Not Available].Semantic proximity Read ↗

[Not Available].Semantic proximity Read ↗

[Not Available].Semantic proximity Read ↗

[JAK2 mutation can be used in diagnosis of myeloproliferative diseases].Semantic proximity Read ↗

[Myeloproliferative neoplasms and related diseases].Semantic proximity Read ↗

[Current Understanding of Myeloproliferative Neoplasm-Related Gene Mutations and Cytokine -Review].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.